Compare CSWC & PLSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CSWC | PLSE |
|---|---|---|
| Founded | 1961 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Textiles | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.5B |
| IPO Year | N/A | 2015 |
| Metric | CSWC | PLSE |
|---|---|---|
| Price | $22.21 | $18.07 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 5 | 1 |
| Target Price | ★ $23.50 | $22.00 |
| AVG Volume (30 Days) | ★ 588.7K | 497.7K |
| Earning Date | 01-01-0001 | 06-01-2026 |
| Dividend Yield | ★ 11.40% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $16.83 | $912.86 |
| Revenue Next Year | $10.26 | $259.66 |
| P/E Ratio | $12.65 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $17.47 | $12.56 |
| 52 Week High | $23.84 | $26.30 |
| Indicator | CSWC | PLSE |
|---|---|---|
| Relative Strength Index (RSI) | 42.11 | 46.32 |
| Support Level | $20.42 | $13.75 |
| Resistance Level | $23.06 | $18.11 |
| Average True Range (ATR) | 0.54 | 1.44 |
| MACD | -0.06 | -0.64 |
| Stochastic Oscillator | 46.00 | 7.31 |
Capital Southwest Corp is a U.S.-based investment company that specializes in providing customized financing to middle market companies across various industries. The company's investment objective is to produce attractive risk-adjusted returns by generating current income from debt investments and capital appreciation from equity and equity related investments. It focuses on providing flexible financing solutions through partnerships with business owners, management teams, and financial sponsors. The company's portfolio may include senior debt, second lien, and subordinated debt, preferred stocks, common stocks, and warrants. The primary source company's revenue comprises interest income and dividend income from investments made as well as management fees.
Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed-Field Ablation or nsPFA technology when used to ablate cellular tissue, can be used to treat a variety of medical conditions for which an optimal solution remains unfulfilled.